Settlements and Verdicts: GlaxoSmithKline. (Feb-06-04)

February 18 2004

A $175 million settlement has been reached and is pending approval in the antitrust class action lawsuit filed regarding the company's nonsteroidal anti-inflammatory product Relafen. (Feb-06-04) [GSK]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in our form on the right to submit your complaint.

Stay Informed

Get the latest on class action lawsuits, settlements & more! Subscribe to our free weekly newsletter.

Get our Newsletter!

Submit a New Complaint

Been wronged by a similar product or service?
Click here to send us your complaint.